Cathepsin S controls adipocytic and osteoblastic differentiation, bone turnover, and bone microarchitecture
- 1 July 2014
- journal article
- Published by Elsevier BV in Bone
- Vol. 64, 281-287
- https://doi.org/10.1016/j.bone.2014.04.022
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund
- P20239-B13
- Amgen
- Boehringer Ingelheim (RA1923/4-2)
- German Research Foundation (HO1875/8-2)
This publication has 42 references indexed in Scilit:
- The proinflammatory cytokines interleukin-1α and tumor necrosis factor α promote the expression and secretion of proteolytically active cathepsin S from human chondrocytesBiological Chemistry, 2013
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJournal of Bone and Mineral Research, 2012
- Selective glucocorticoid receptor modulation maintains bone mineral density in miceJournal of Bone and Mineral Research, 2012
- OPG-Fc Treatment in Growing Pigs Leads to Rapid Reductions in Bone Resorption Markers, Serum Calcium, and Bone Formation MarkersHormone and Metabolic Research, 2011
- Pharmacological Inhibition of Cathepsin S Decreases Atherosclerotic Lesions in Apoe-/- MiceJournal of Cardiovascular Pharmacology, 2010
- Leukocyte Cathepsin S Is a Potent Regulator of Both Cell and Matrix Turnover in Advanced AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Cathepsin K Null Mice Show Reduced Adiposity during the Rapid Accumulation of Fat StoresPLOS ONE, 2007
- Increased serum cathepsin S in patients with atherosclerosis and diabetesAtherosclerosis, 2006
- Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesisThe FASEB Journal, 2005
- Age-Related Bone Loss: Old Bone, New FactsGerontology, 2002